Bayer CropScience AG v. Dow AgroSciences LLC, No. 13-1002 (Fed. Cir. Sept. 3, 2013)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
When the inventors applied for the patent at issue, they had sequenced one gene coding for one enzyme, using a test purportedly capable of finding other, similar genes. In writing its claims, the owner —now Bayer CropScience AG—decided to claim a broad cat egory based on the function of the particular enzyme, defining the category by using a term with an established scientific meaning.
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error